Open AccessCardiovascular Complications during COVID-19 Infection
Author(s) -
Radha Saraswathy
Publication year - 2020
Publication title -
advances in clinical toxicology
Language(s) - English
Resource type - Journals
ISSN - 2577-4328
DOI - 10.23880/act-16000196
Subject(s) - coronavirus , medicine , pandemic , pneumonia , outbreak , disease , covid-19 , transmission (telecommunications) , diabetes mellitus , intensive care medicine , virology , immunology , infectious disease (medical specialty) , endocrinology , electrical engineering , engineering
In December 2019 a serious outbreak of pneumonia emerged in china. The infection Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), spreads the infection rapidly from China to other countries, and the World Health Organization (WHO) announced Coronavirus disease 2019 (COVID-19) a pandemic. Coronaviruses (CoV) contain a single-stranded RNA genome. The Coronavirus infected through respiratory droplets will be a high-level of transmission and to develop acute respiratory failure but a large portion of patients exploit cardiovascular manifestations. The WHO has stated by august 2020 that 26,171,112 confirmed COVID-19 positive cases and 865,154 deaths were determined all over the world. COVID-19 the consequential hazards to the public health care system of COVID-19 infection for people underlying medical problems have a significantly increased risk of death, especially the ones carrying hypertension, diabetes, cardiovascular diseases, and cerebrovascular disease. Possible vaccines and drugs to treat COVID-19 infection are undergoing. This review discussed cardiovascular complications in severe acute respiratory syndrome produced by coronavirus-2 (SARS-CoV-2).